7 March 2018
Market snapshot
Equities - India
Close
Chg .%
Sensex
33,317
-1.3
Nifty-50
10,249
-1.1
Nifty-M 100
19,098
-1.2
Equities-Global
Close
Chg .%
S&P 500
2,728
0.3
Nasdaq
7,372
0.6
FTSE 100
7,147
0.4
DAX
12,114
0.2
Hang Seng
12,312
2.7
Nikkei 225
21,418
1.8
Commodities
Close
Chg .%
Brent (US$/Bbl)
65
0.0
Gold ($/OZ)
1,335
1.1
Cu (US$/MT)
6,966
1.3
Almn (US$/MT)
2,129
-0.1
Currency
Close
Chg .%
USD/INR
65.0
-0.2
USD/EUR
1.2
0.6
USD/JPY
106.1
-0.1
YIELD (%)
Close
1MChg
10 Yrs G-Sec
7.8
0.00
10 Yrs AAA Corp
8.4
0.00
Flows (USD b)
6-Mar
MTD
FIIs
0.1
0.1
DIIs
-0.1
-0.3
Volumes (INRb)
6-Mar
MTD*
Cash
332
326
F&O
7,151
8,371
Note: YTD is calendar year, *Avg
YTD.%
-2.2
-2.7
-9.6
YTD.%
2.0
6.8
-7.0
-6.2
5.1
-5.9
YTD.%
-2.1
2.4
-3.3
-5.6
YTD.%
1.7
3.3
-5.8
YTDchg
0.5
0.5
YTD
0.1
2.7
YTD*
399
7,852
Today’s top research idea
Sun Pharma: No data integrity issue at Halol; resolution likely
over coming months
The USFDA inspected Sun Pharma’s (SUNP) Halol plant from 12-23 February
2018. Notably, the number of observations has come down to three this time
from nine in the last inspection that was conducted in December 2016. This
facility contributes 10-13% of US sales for the company.
Given that none of the three observations are serious in nature (not related to
data integrity), we expect resolution of the facility over the coming few
months.
Resolution of the Halol facility is critical for the company, as its US business has
been under pressure after the issuance of the warning letter. Resolution will
provide visibility on key approvals, including Xelpros, Elepsia and Vagifem.
Research covered
Cos/Sector
Sun Pharma
Staffing
Consumer
Key Highlights
No data integrity issue at Halol; resolution likely over coming months
Making hay while the sun shines
Haryana makes Aadhar, invoice mandatory for retail liquor vends
Piping hot news
Commercial coal mining may cut import bill by
₹30,000
cr
The move to allow the private sector to mine coal for commercial use will boost
both production and mining efficiency. Substitution of imported non-coking coal
with domestic production can save about INR30,000 crore of coal imports, …
Chart of the Day: Sun Pharma – No data integrity issue at Halol; resolution likely over
coming months
US generic sales to improve FY19 onward
Source: Company, MOSL
Research Team (Gautam.Duggad@MotilalOswal.com)
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.